Oncogenic actions of HDGF (hepatoma-derived growth factor) in colorectal cancer: implication for tumor biology/patient prognosis and modulation by butyrate

被引：0
|
作者：
Melcher, R. [1 ]
Kudlich, T. [1 ]
Rogoll, D. [1 ]
Grell, A. [1 ]
Neun, T. [1 ]
Wilk, M. [1 ]
Luehrs, H. [1 ]
Einsele, H. [1 ]
Scheurlen, M. [1 ]
机构：
[1] Dept Med 2, Wurzburg, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：55 / 55
页数：1
相关论文
共 50 条
  • [21] HDGF (hepatoma-derived growth factor)-silencing inhibits the proliferation of hepatoma cells through a sorafenib-independent pathway
    Enomoto, Hirayuki
    Nakamura, Hideji
    Imanishi, Hiroyasu
    Ishii, Noriko
    Yuri, Yukihisa
    Aoki, Tomoko
    Yoh, Kazunori
    Ishii, Akio
    Takashima, Tomoyuki
    Aizawa, Nobuhiro
    Sakai, Yoshiyuki
    Iwata, Kazunari
    Ikeda, Naoto
    Tanaka, Hironori
    Iwata, Yoshinori
    Saito, Masaki
    Iijima, Hiroko
    Nishiguchi, Shuhei
    HEPATOLOGY, 2013, 58 : 1068A - 1068A
  • [22] Expression of Hepatoma-derived Growth Factors is Correlated with Prognosis of Oral Cancer and Vascular Endothelial Growth Factor
    Lin, Y.
    Li, C.
    Lin, L.
    Yen, C.
    Tai, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S533 - S533
  • [23] Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells
    Giri, Karuna
    Pabelick, Christina M.
    Mukherjee, Priyabrata
    Prakash, Y. S.
    APOPTOSIS, 2016, 21 (03) : 329 - 339
  • [24] Hepatoma derived growth factor (HDGF) dynamics in ovarian cancer cells
    Karuna Giri
    Christina M. Pabelick
    Priyabrata Mukherjee
    Y. S. Prakash
    Apoptosis, 2016, 21 : 329 - 339
  • [25] Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells
    Liao, Fei
    Liu, Meng
    Lv, Li
    Dong, Weiguo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 645 (1-3) : 55 - 62
  • [26] Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis
    Nakamura, H
    Yoshida, K
    Kishima, Y
    Enomoto, H
    Uyama, H
    Okuda, TKY
    Hirotani, T
    Ito, H
    Kawase, I
    HEPATO-GASTROENTEROLOGY, 2004, 51 (56) : 470 - 475
  • [27] Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer
    Lian, Jiayan
    Tang, Jianming
    Shi, Huijuan
    Li, Hui
    Zhen, Tiantian
    Xie, Wenlin
    Zhang, Fenfen
    Yang, Yang
    Han, Anjia
    ONCOTARGET, 2015, 6 (30) : 29357 - 29374
  • [28] Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis
    Chen, San-Cher
    Hu, Tsung-Hui
    Huang, Chao-Cheng
    Kung, Mei-Lang
    Chu, Tian-Huei
    Yi, Li-Na
    Huang, Shih-Tsung
    Chan, Hoi-Hung
    Chuang, Jiin-Haur
    Liu, Li-Feng
    Wu, Han-Chung
    Wu, Deng-Chyang
    Chang, Min-Chi
    Tai, Ming-Hong
    ONCOTARGET, 2015, 6 (18): : 16253 - 16270
  • [29] Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer
    Uyama, Hirokazu
    Tomita, Yasuhiko
    Nakamura, Hideji
    Nakamori, Shoji
    Zhang, Binglin
    Hoshida, Yoshihiko
    Enomoto, Hirayuki
    Okuda, Yorihide
    Sakon, Masato
    Aozasa, Katsuyuki
    Kawase, Ichiro
    Hayashi, Norio
    Monden, Morito
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6043 - 6048
  • [30] SiRNA targeting hepatoma-derived growth factor (HDGF) inhibits growth of non-small cell lung cancer in xenograft models.
    Zhang, Jun
    Mao, Li
    CANCER RESEARCH, 2006, 66 (08)
12345